Gilgamesh Pharmaceuticals, Inc.

United States of America

 
Total IP 56
Total IP Rank # 24,653
IP Activity Score 2.8/5.0    78
IP Activity Rank # 9,025
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

20 1
8 0
27 0
0
 
Last Patent 2025 - N-methylethan-1-amine or a pharm...
First Patent 2020 - Arylcyclohexylamine derivatives ...
Last Trademark 2022 - GILGAMESH PHARMACEUTICALS
First Trademark 2022 - GILGAMESH PHARMACEUTICALS

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention N-methylethan-1-amine or a pharmaceutically acceptable salt thereof. NHNN-methylethan-1-amine or ...
Invention Methods of treating psychiatric disorders or pain using (r)-2-(4-fluorophenyl)-2-(methylamino)cyc...
Invention Crystalline hydrochloride salts of n-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine. The...
Invention Pyridine derivatives for treating psychiatric disorders. 1234566 are as defined herein. It also r...
Invention Crystalline salts of n-ethyl-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine. The present disclos...
Invention Novel phenalkylamines and their use in the treatment of psychiatric disorders. The present disclo...
Invention Crystalline hydrochloride and fumarate salts of n-ethyl-2- (5-fluoro-1h-indol-3-yl)-n-methylethan...
Invention Crystalline salts of n-ethyl-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine. NHNNHNNHNNHNNHNN-met...
Invention Methods of treating mood disorders. Methods of treating mood disorders with compounds disclosed ...
Invention Crystalline salts of 2-phenyl-2-aminocyclohexan-1-one derivatives. RR)-2-(4-fluorophenyl)-2-(meth...
Invention Novel ergolines and methods of treating mood disorders. The present disclosure provides ergoline ...
Invention Negative allosteric modulators of glun2b receptors and methods of making and using the same. The ...
2023 Invention Synthesis of 2-phenyl-2-amino-cyclohexan-1-one derivatives. The present disclosure relates to a p...
Invention Methods of using trazodone to reverse the effects of 5-ht2a receptor agonists. The present disclo...
Invention Crystalline fumarate salts of n-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine. The prese...
Invention Crystalline hydrochloride salts of n-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine. The ...
Invention Crystalline salts of n-ethyl-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine. The present disclosu...
Invention Phenalkylamines and methods of making and using the same. The present disclosure provides phenalk...
Invention Tryptamines and methods of treating mood disorders
Invention Tryptamines and methods of treating mood disorders. Novel tryptamine compounds according to Formu...
Invention Pyridine derivatives for treating psychiatric disorders. The present disclosure relates to a comp...
Invention (ampar-pam)-nmda receptor antagonist combination therapy for treatment of mental conditions and d...
Invention (ampa-pam)-nmda receptor antagonist combination therapy for treatment of mental conditions and di...
2022 Invention Combinations of peripheral 5-ht2a receptor antagonists and central 5-ht2a receptor agonists. Met...
Invention Combinations of peripheral 5-ht2a receptor antagonists and central 5-ht2a receptor agonists. Meth...
G/S Pharmaceuticals, namely, pharmaceutical and drug preparations and substances for use in treating ...
Invention Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders. Provide...
Invention Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders. Provided...
Invention Methods of treating neuropsychiatric disorders. The disclosure provides, in part, a method of tr...
Invention Methods of treating neuropsychiatric disorders. The disclosure provides, in part, a method of tre...
Invention Novel tryptamines and methods of treating mood disorders. Novel tryptamines and methods of treati...
Invention Novel ergolines and methods of treating mood disorders. The present disclosure provides ergoline...
Invention Phenalkylamines and methods of making and using the same. The present disclosure provides phenal...
2021 Invention Methods of treating mood disorders. Methods of treating mood disorders with compounds disclosed h...
Invention Azetidinyl tryptamines and methods of treating psychiatric disorders. The present disclosure inc...
Invention Azetidinyl tryptamines and methods of treating psychiatric disorders. The present disclosure incl...
Invention Phenalkylamines and methods of treating mood disorders. Phenalkylamines and methods of treating ...